| Database ID | Agent | Target | Cancer Type | Detail |
| DB00016 | bevacizumab | Vascular endothelial growth factor
Epidermal growth factor receptor | colorectal cancer | view |
| DB00017 | aflibercept | VEGFA, vascular endothelial growth factor B, PIGF | colorectal cancer | view |
| DB00018 | regorafenib | Protooncogene tyrosineprotein kinase receptor ret
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Vascular endothelial growth factor receptor 3 | colorectal cancer | view |
| DB00019 | bevacizumab | Vascular endothelial growth factor
Epidermal growth factor receptor | colorectal cancer | view |
| DB00020 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00021 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00022 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00023 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00024 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00025 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00026 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00027 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00028 | cetuximab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00029 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |
| DB00030 | panitumumab | Epidermal growth factor receptor | colorectal cancer | view |